In the future, additional gene therapies based on ANG mutations are expected to be explored, combining advances in the pathogenic mechanism of ANG, CNS targeting, gene delivery, and gene editing and knockdown technologies to open up new perspectives for ALS treatment. This evidence concerns the gene ANG and amyotrophic lateral sclerosis.